Newsroom

Sorted by: Latest

-

PitchBook Opens Its Platform to Startups for Free and Launches PitchBook Origin to Help Investors Find Opportunities Earlier

LISBON, Portugal--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence provider, today announced two new offerings at Web Summit 2026: PitchBook for Startups, which provides free access to PitchBook for companies that are seeking to raise their first institutional financing, and PitchBook Origin, a standalone, AI-native offering purpose-built for early-stage venture deal sourcing covering roughly 25 million companies and 250 million people profiles at launch. The releases m...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 09.11.2026 FEUD IE00BF2FL590 335,317.00 EUR 18,923,460.03 56.435  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 09.11.2026 FEUZ IE00B8X9NY41 1,581,130.00 EUR 102,846,952.75 65.046  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 09.11.2026 FEM IE00B8X9NX34 300,002.00 USD 14,350,777.93 47.836  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 09.11.2026 FEXD.LN IE00BWTNMB87 440,903.00 USD 44,421,250.56 100.751  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 09.11.2026 FEX.LN IE00B8X9NW27 1,372,712.00 USD 156,465,778.21 113.983  ...
-

Gibraltar to Present at the 18th Annual Southwest IDEAS Conference

BUFFALO, N.Y.--(BUSINESS WIRE)--Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential and agtech markets, today announced that Chairman and Chief Executive Officer Bill Bosway and Vice President, Corporate Controller Lori Rizzo are scheduled to present at the 18th Annual Southwest IDEAS Conference on Thursday, November 19, 2026 at 9:55 a.m. CT and hold meetings with investors that day.The presentation webcast can be accessed t...
-

FSC Franchise Co. Selects PAR Technology for Loyalty, Ordering, and Catering Partner Across Its Restaurant Brands

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--PAR Technology Corporation (NYSE: PAR), a leading technology provider powering multi-unit operators across restaurant, retail, and large-scale commerce, today announced that FSC Franchise Co. ("FSC"), franchisor of Beef ‘O' Brady's, The Brass Tap, and Newk's Eatery, has selected PAR® Punchh®, PAR Ordering™, and PAR Catering as its recommended solutions across its restaurant brands, creating a more connected technology foundation with PAR Intelligence, PAR’s...
-

Mirum Pharmaceuticals Announces Primary Endpoint Met in AZURE-4 Phase 3 Study and Highlights Long-Term Brelovitug Data Presented at AASLD

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Primary Endpoint Met in AZURE-4 Phase 3 Study and Highlights Long-Term Brelovitug Data Presented at AASLD...
-

Veradermics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today reported financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinical progress. “This has been a defining year for Veradermics as we advanced the development of VDPHL01 as a potential treatment for pattern hair loss in both men and wome...